Literature DB >> 22198413

Limits on risks for healthy volunteers in biomedical research.

David B Resnik1.   

Abstract

Healthy volunteers in biomedical research often face significant risks in studies that offer them no medical benefits. The U.S. federal research regulations and laws adopted by other countries place no limits on the risks that these participants face. In this essay, I argue that there should be some limits on the risks for biomedical research involving healthy volunteers. Limits on risk are necessary to protect human participants, institutions, and the scientific community from harm. With the exception of self-experimentation, limits on research risks faced by healthy volunteers constitute a type of soft, impure paternalism because participants usually do not fully understand the risks they are taking. I consider some approaches to limiting research risks and propose that healthy volunteers in biomedical research should not be exposed to greater than a 1% chance of serious harm, such as death, permanent disability, or severe illness or injury. While this guideline would restrict research risks, the limits would not be so low that they would prevent investigators from conducting valuable research. They would, however, set a clear upper boundary for investigators and signal to the scientific community and the public that there are limits on the risks that healthy participants may face in research. This standard provides guidance for decisions made by oversight bodies, but it is not an absolute rule. Investigators can enroll healthy volunteers in studies involving a greater than 1% chance of serious harm if they show that the research addresses a compelling public health or social problem and that the risk of serious harm is only slightly more than 1%. The committee reviewing the research should use outside experts to assess these risks.

Entities:  

Mesh:

Year:  2012        PMID: 22198413      PMCID: PMC3443860          DOI: 10.1007/s11017-011-9201-1

Source DB:  PubMed          Journal:  Theor Med Bioeth        ISSN: 1386-7415


  18 in total

1.  The ethical challenge of infection-inducing challenge experiments.

Authors:  F G Miller; C Grady
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

2.  Mengele's birthmark: the Nuremberg Code in United States courts.

Authors:  George J Annas
Journal:  J Contemp Health Law Policy       Date:  1991

3.  Assessing research risks systematically: the net risks test.

Authors:  D Wendler; F G Miller
Journal:  J Med Ethics       Date:  2007-08       Impact factor: 2.903

4.  Facing up to paternalism in research ethics.

Authors:  Franklin G Miller; Alan Wertheimer
Journal:  Hastings Cent Rep       Date:  2007 May-Jun       Impact factor: 2.683

5.  General justifications for public health regulation.

Authors:  Lawrence O Gostin
Journal:  Public Health       Date:  2007-08-27       Impact factor: 2.427

6.  Public trust and research a decade later: what have we learned since Jesse Gelsinger's death?

Authors:  Mark Yarborough; Richard R Sharp
Journal:  Mol Genet Metab       Date:  2009-02-20       Impact factor: 4.797

7.  Limits to research risks.

Authors:  F G Miller; S Joffe
Journal:  J Med Ethics       Date:  2009-07       Impact factor: 2.903

8.  A framework for risk-benefit evaluations in biomedical research.

Authors:  Annette Rid; David Wendler
Journal:  Kennedy Inst Ethics J       Date:  2011-06

9.  A national registry for healthy volunteers in phase 1 clinical trials.

Authors:  David B Resnik; Greg Koski
Journal:  JAMA       Date:  2011-03-15       Impact factor: 56.272

Review 10.  Living donor kidney transplantation: an update on evaluation and medical implications of donation.

Authors:  J J Taliercio; S Nurko; E D Poggio
Journal:  Minerva Urol Nefrol       Date:  2011-03       Impact factor: 3.720

View more
  13 in total

1.  Deliberate Microbial Infection Research Reveals Limitations to Current Safety Protections of Healthy Human Subjects.

Authors:  David L Evers; Carol B Fowler; Jeffrey T Mason; Rebecca K Mimnall
Journal:  Sci Eng Ethics       Date:  2014-08-24       Impact factor: 3.525

2.  Ethical Criteria for Human Challenge Studies in Infectious Diseases.

Authors:  Ben Bambery; Michael Selgelid; Charles Weijer; Julian Savulescu; Andrew J Pollard
Journal:  Public Health Ethics       Date:  2015-09-27       Impact factor: 1.940

3.  Setting risk thresholds in biomedical research: lessons from the debate about minimal risk.

Authors:  Annette Rid
Journal:  Monash Bioeth Rev       Date:  2014 Mar-Jun

4.  Paternalism and utilitarianism in research with human participants.

Authors:  David B Resnik
Journal:  Health Care Anal       Date:  2015-03

5.  Unequal treatment of human research subjects.

Authors:  David B Resnik
Journal:  Med Health Care Philos       Date:  2015-02

6.  The Role of Intuition in Risk/Benefit Decision-Making in Human Subjects Research.

Authors:  David B Resnik
Journal:  Account Res       Date:  2016-06-13       Impact factor: 2.622

7.  Standards of evidence for institutional review board decision-making.

Authors:  David B Resnik
Journal:  Account Res       Date:  2020-12-08       Impact factor: 3.057

8.  Strategy for recruitment and factors associated with motivation and satisfaction in a randomized trial with 210 healthy volunteers without financial compensation.

Authors:  Quentin Luzurier; Cédric Damm; Fabien Lion; Carine Daniel; Lucille Pellerin; Marie-Pierre Tavolacci
Journal:  BMC Med Res Methodol       Date:  2015-01-05       Impact factor: 4.615

9.  Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading.

Authors:  Karine Dubé; Lynda Dee
Journal:  J Virus Erad       Date:  2020-04-30

10.  Challenging research on human subjects: justice and uncompensated harms.

Authors:  Stephen Napier
Journal:  Theor Med Bioeth       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.